Increase in secretion of glial cell line-derived neurotrophic factor from glial cell lines by inhibitors of vacuolar ATPase

Neurochemistry International

Volumn 42, Issue 6, 2003, Pages 493-498

  Nishiguchi, Mariko ^a   Tokugawa, Kimiko ^a   Yamamoto, Kyoko ^a   Akama, Tomoko ^a   Nozawa, Yuriko ^a   Chaki, Shigeyuki ^a   Ueki, Tomokazu ^a   Kameo, Kazuya ^a   Okuyama, Shigeru ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Glial cell line derived neurotrophic factor; Glial cell lines; Vacuolar ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE INHIBITOR; BAFILOMYCIN A1; CALCIUM IONOPHORE; CONCANAMYCIN A; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; PHORBOL ESTER;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GLIA CELL; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOMYCES; STREPTOMYCES DIASTATOCHROMOGEN;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CALCIMYCIN; CONCANAVALIN A; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MACROLIDES; NERVE GROWTH FACTORS; NEUROGLIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VACUOLAR PROTON-TRANSLOCATING ATPASES;

STREPTOMYCES;

EID: 0037401990     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00139-0     Document Type: Article

References (30)

1. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Bandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
2. Bishop J.F., Wang W., Mueller G.P., Mouradiam M.M. Effects of elevated intracellular calcium on GDNF expression. Soc. Neurosci. Abs. 21:1995;100.
3. Bowman E.J., Siebers A., Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPase from microorganisms animal cells and plant cells. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7972-7976.
4. Buj-Bello A., Buchman V.L., Horton A., Rosenthal A., Davies A.M. GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron. 15:1995;821-828.
5. Choi-Lundberg D.L., Lin O., Chang Y., Chang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
6. Connop B.P., Thies R.L., Beyreuther K., Ida N., Reiner P.B. Novel effects of FCCP carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone on amyloid precursor protein processing. J. Neurochem. 72:1999;1457-1465.
7. Drose S., Altendorf K. Bafilimycins and concanamycins as inhibitors of V-ATPase and P-ATPases. J. Exp. Biol. 200:1997;1-8.
8. Drose S., Bindseil K.U., Bowman E.J., Siebers A., Zeeck A., Altendorf K. Inhibitory effect of modified bafilomycins and concanamycins on P- and V- type adenosine triphosphatases. Biochemistry. 32:1993;3902-3906.
9. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russel D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
10. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simpson L.C., Moffet B., Vandlen A., Koliatsos V.E., Rosenthal A. GDNF: a potent survival factor for motorneurons present in peripheral nerve and muscle. Science. 266:1994;1054-1062.
11. Hou J.G.G., Lin L.F.H., Mytilineou C. Glial cell derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66:1996;74-82.
12. +-ATPases-targets for drug discovery? Ann. N.Y. Acad. Sci. 834:1997;600-608.
13. Kinashi H., Someuo K., Sakaguchi K. Isolation and characterization of concentration of concanamycin A B and C. J. Antibiot. 37:1984;1333-1342.
14. Knops J., Suomensaari S., Lee M., McConlogue L., Seubert P., Sinha S. Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, a selective inhibitor of vacuolar ATPases. J. Biol. Chem. 270:1995;2419-2422.
15. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neuritrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
16. Lin L.F., Zhang T.J., Collins F., Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
17. Manabe Y., Nagano I., Gazi M.S., Murakami T., Shiote M., Shoji M., Kitagawa H., Setoguchi Y., Abe K. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis. Apoptosis. 7:2002;329-334.
18. McGeer P.L., Itagaki S., Akiyama H., Mcgeer E.H. Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24:1988;574-576.
19. Mehta A.K., Ticku M.K. An update on GABAA receptors. Brain Res. Brain Res. Rev. 2-3:1999;196-217.
20. Rabey J.H. Second generation of dopamine agonists: pros and cons. J. Neural Transm. 45(Suppl.):1995;213-224.
21. Sauer H., Rosennblad C., Bjorklund A. GDNF but not TGF-β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine-lesion. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8935-8939.
22. Stefan D. Bafilomycins and Concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1997;1-8.
23. Stephenson F.A. Subunit characterization of NMDA receptors. Curr. Drug Targets. 3:2001;233-239.
24. Suter-Crazzolara C., Unisiker K. GDNF mRNA levels are induced by FGF-2 in rat C6 glioblastoma cells. Mol. Brain Res. 41:1996;175-182.
25. Tomac A., Lindgvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
26. Verity A.N., Wyatt T.L., Hajos B., Eglen R.M., Baecker P.A., Johnson R.M. Reguration of glial cell line-derived neurotrophic factor release from rat C6 glioblastoma cells. J. Neurochem. 70:1998;531-539.
27. Verity A.N., Wyatt T.L., Lee W., Hajos B., Baecker P.A., Eglen R.M., Johnson R.M. Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J. Neurosci. Res. 55:1999;187-197.
28. Wang Y., Chang C.F., Morales M., Chiang Y.H., Hoffer J. Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann. N.Y. Acad. Sci. 962:2002;423-437.
29. Yan Q., Matheson C., Lopez O.T. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature. 373:1995;341-344.
30. Zhang W.R., Sato K., Iwai M., Nagano I., Manabe Y., Abe K. Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat. Brain Res. 947:2002;140-145.